GlassScriptPhysician profile
Scott M Katzen
NPI 1760523724
$3,940.71
in general payments reported to CMS, 2019-2025
13 companies · $670 in 2025
The $670 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $176 · 2021: $225 · 2022: $557 · 2023: $695 · 2024: $1,211 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,194 · Travel and Lodging: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,193.83 |
| Travel and Lodging | $382.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,240.65 | 2021-2025 | Corevalve Evolut R, Selectsecure, Cobalt Dr Mri Surescan |
| Shockwave Medical, INC | $546.37 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $508.32 | 2021-2025 | Nc Trek Neo, Viewmate, Xience Skypoint |
| Penumbra, INC. | $471.15 | 2024 | Indigo System |
| Boston Scientific Corporation | $372.15 | 2019-2025 | Ekosonic |
| Medtronic Vascular, INC. | $212.81 | 2019-2020 | |
| Chiesi USA, INC. | $180.74 | 2025 | Kengreal |
| Cardiovascular Systems INC. | $145.24 | 2020 | |
| Teleflex LLC | $107.26 | 2022-2025 | Guideliner |
| Janssen Pharmaceuticals, INC | $73.26 | 2019-2023 | Xarelto |
| Biotronik Nro, INC. | $35.54 | 2025 | Prospera |
| Novartis Pharmaceuticals Corporation | $31.31 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $15.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Katzen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.